← Back to Search

Behavioural Intervention

Exercise with Blood Flow Restriction for Muscle Strengthening

N/A
Waitlist Available
Led By Brennan J Thompson, PhD
Research Sponsored by Utah State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks
Awards & highlights

Study Summary

This trial will explore if adding restricted blood flow to exercise can improve muscle strength and size. #exercise #fitness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Eccentron maximal muscle strength
Local muscle hypertrophy
Muscle function
+1 more
Secondary outcome measures
Muscle Tissue

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Eccentric plus blood-flow restrictionExperimental Treatment1 Intervention
This is the experimental condition involving the eccentric resistance training with blood flow restriction.
Group II: Eccentric only trainingActive Control1 Intervention
This is the experimental control; where this group will be used as the standard active comparison condition.

Find a Location

Who is running the clinical trial?

Utah State UniversityLead Sponsor
44 Previous Clinical Trials
4,412 Total Patients Enrolled
1 Trials studying Blood Flow Restriction
45 Patients Enrolled for Blood Flow Restriction
Sara HarperLead Sponsor
1 Previous Clinical Trials
35 Total Patients Enrolled
Brennan J Thompson, PhDPrincipal InvestigatorUtah State Univeristy
2 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

Eccentric plus blood-flow restriction (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04977804 — N/A
Blood Flow Restriction Research Study Groups: Eccentric only training, Eccentric plus blood-flow restriction
Blood Flow Restriction Clinical Trial 2023: Eccentric plus blood-flow restriction Highlights & Side Effects. Trial Name: NCT04977804 — N/A
Eccentric plus blood-flow restriction (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04977804 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 85 or younger entitled to participate in this medical experiment?

"This medical study is recruiting participants aged 18 and above, but below 30 years old."

Answered by AI

Is enrollment currently open for this research endeavor?

"Clinicaltrials.gov reveals that this clinical trial is still in search of participants, having been posted on October 30th 2022 and last updated on May 8th 2023."

Answered by AI

Who can gain admittance to this experiment?

"Candidates for this medical trial must meet the criteria of 18-30 years old and evidence blood flow restriction. Currently, there is room to enroll an additional 30 participants into the study."

Answered by AI

What is the capacity of participants for this medical trial?

"Affirmative. The clinicaltrials.gov page of this medical experiment, which was posted on October 30th 2022, indicates that it is presently recruiting participants. Only 30 patients need to be sourced from 1 site for the study to reach completion."

Answered by AI
~0 spots leftby Jun 2025